SCHEMBL6005341

SCHEMBL6005341

COc1ccc(OC)c(NC(=O)O)c1

nearest known ligand 0.69

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GAA P10253 6/20 0.69
TP53 P04637 1/20 0.69
MAPT P10636 5/20 0.68
SMN1; SMN2 Q16637 1/20 0.68
KMT2A Q03164 6/20 0.67
NPSR1 Q6W5P4 2/20 0.67
MEN1 O00255 5/20 0.66
MAPK1 P28482 2/20 0.63
ALDH1A1 P00352 2/20 0.62
POLB P06746 1/20 0.61
HPGD P15428 1/20 0.61
HTT P42858 1/20 0.60
NPC1 O15118 1/20 0.59
RAB9A P51151 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19427718 0.87 MAPT (0.79) GAATP53MAPTSMN1; SMN2KMT2A
SCHEMBL5833241 0.86 ALDH1A1 (0.73) GAAMAPTSMN1; SMN2KMT2ANPSR1
SCHEMBL2502603 0.86 MAPT (0.71) GAATP53MAPTSMN1; SMN2KMT2A
SCHEMBL11660471 0.86 MAPT (0.70) GAATP53MAPTSMN1; SMN2KMT2A
SCHEMBL20357354 0.84 GAA (0.51) GAATP53MAPTSMN1; SMN2KMT2A
SCHEMBL167053 0.84 GAA (0.67) GAATP53MAPTSMN1; SMN2KMT2A
SCHEMBL862532 0.84 TSHR (0.70) GAATP53MAPTSMN1; SMN2KMT2A
SCHEMBL3704664 0.84 GAA (0.61) GAATP53MAPTSMN1; SMN2KMT2A
SCHEMBL14338700 0.83 MAPT (0.68) GAATP53MAPTSMN1; SMN2KMT2A
SCHEMBL29826604 0.82 TP53 (0.83) GAATP53MAPTSMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1353926-B1 MIKANOLIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USES SOD CONSEILS RECH APPLIC (FR) 2006-03-08 EP claimed
JP-2004533456-A 2004-11-04 JP claimed
EP-1438039-A2 PRODUCT COMPRISING MIKANOLIDE, DIHYDROMIKANOLIDE OR AN ANALOGUE THEREOF COMBINED WITH ANOTHER ANTI-CANCER AGENT FOR THERAPEUTIC USE IN CANCER TREATMENT SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2004-07-21 EP claimed
EP-1353926-A1 MIKANOLIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USES Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) (FR) 2003-10-22 EP claimed
WO-2002096348-A2 PRODUCT COMPRISING MIKANOLIDE, DIHYDROMIKANOLIDE OR AN ANALOGUE THEREOF COMBINED WITH ANOTHER ANTI-CANCER AGENT FOR THERAPEUTIC USE IN CANCER TREATMENT SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2002-12-05 WO claimed
WO-2002055523-A1 MIKANOLIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USES SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2002-07-18 WO claimed
EP-1353926-B1 MIKANOLIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USES SOD CONSEILS RECH APPLIC (FR) 2006-03-08 EP disclosed
EP-1438039-A2 PRODUCT COMPRISING MIKANOLIDE, DIHYDROMIKANOLIDE OR AN ANALOGUE THEREOF COMBINED WITH ANOTHER ANTI-CANCER AGENT FOR THERAPEUTIC USE IN CANCER TREATMENT SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2004-07-21 EP disclosed
EP-1353926-A1 MIKANOLIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USES Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) (FR) 2003-10-22 EP disclosed
WO-2002096348-A2 PRODUCT COMPRISING MIKANOLIDE, DIHYDROMIKANOLIDE OR AN ANALOGUE THEREOF COMBINED WITH ANOTHER ANTI-CANCER AGENT FOR THERAPEUTIC USE IN CANCER TREATMENT SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2002-12-05 WO disclosed
WO-2002055523-A1 MIKANOLIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USES SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2002-07-18 WO disclosed